|
|
 Vaprisol Information - August 30, 2008
| Astellas Pharma U.S. Inc. says Friday that the FDA has approved a new drug for hospital patients suffering from life-threatening low sodium levels. The drug, being marketed as Vaprisol, is intravenous and could be used to treat euvolemic hyponatremia, a condition that can occur in hospital patients suffering from afflictions like kidney failure, cancer, chronic high blood pressure and more | | Astellas Pharma U.S. Inc. said Friday that the FDA has approved a new drug for hospital patients suffering from life-threatening low sodium levels. The drug, being marketed as Vaprisol, is intravenous and could be used to treat euvolemic hyponatremia, which is a condition that can occur in hospital patients suffering from afflictions like kidney failure, cancer, chronic high blood pressure and more | | Astellas Pharma U.S. Inc. said Friday that the FDA has approved a new drug for hospital patients suffering from life-threatening low sodium levels. The drug, being marketed as Vaprisol, is intravenous and could be used to treat euvolemic hyponatremia, which is a condition that can occur in hospital patients suffering from afflictions like kidney failure, cancer, chronic high blood pressure and more | |
|
|
